{"id":23116,"date":"2016-07-13T08:42:29","date_gmt":"2016-07-13T07:42:29","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=23116"},"modified":"2016-07-13T08:42:29","modified_gmt":"2016-07-13T07:42:29","slug":"tractaments-de-tabaquisme-presentacio-de-lestudi-eagles","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","title":{"rendered":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/estudi-eagles-portada.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-23120\" alt=\"estudi-eagles-portada\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/estudi-eagles-portada.jpg\" width=\"272\" height=\"199\" \/><\/a>L&#8217;<b>estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) <\/b>\u00e9s un <strong>treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics<\/strong>. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat per la\u00a0<a href=\"http:\/\/www.academia.cat\/\" target=\"_blank\" rel=\"noopener\">Societat Catalana d&#8217;Atenci\u00f3 i Tractament del Consum del Tabac (SCATT)<\/a> en col\u00b7laboraci\u00f3 amb el Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya, el Col\u00b7legi de Farmac\u00e8utics de Barcelona i l\u2019Acad\u00e8mia de Ci\u00e8ncies M\u00e8diques de Catalunya i de Balears.<\/p>\n<figure id=\"attachment_23124\" aria-describedby=\"caption-attachment-23124\" style=\"width: 306px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-1.jpg\"><img decoding=\"async\" class=\"wp-image-23124   \" alt=\"presentacio-estudi-EAGLES-tabaquisme-COFB (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-1.jpg\" width=\"306\" height=\"204\" \/><\/a><figcaption id=\"caption-attachment-23124\" class=\"wp-caption-text\">D&#8217;esquerra a dreta: Eugeni Bruguera, Guillermo Bagaria, \u00c0ngela Mart\u00ednez i S\u00edlvia Mond\u00f3n<\/figcaption><\/figure>\n<p>L\u2019acte va anar a c\u00e0rrec d&#8217;<b>Eugeni Bruguera<\/b>, cap de la Unitat de Conductes Addictives i de la Unitat de Tabaquisme del Servei de Psiquiatria de l&#8217;Hospital Universitari Vall d&#8217;Hebron de Barcelona, i\u00a0<b>Silvia Mond\u00f3n<\/b>, de la Unitat de Conductes Addictives del Servei de Psiquiatria de l&#8217;Institut de Neuroci\u00e8ncies de l&#8217;Hospital Cl\u00ednic de Barcelona, dos dels tres investigadors principals, juntament amb <b>Cristina Pinet<\/b>. Van presentar <b>\u00c0ngela Mart\u00ednez<\/b>, presidenta de l&#8217;SCATT, i <b>Guillermo Bagaria<\/b>, vocal de la Junta de Govern del COFB.<\/p>\n<div class=\"box shadow\">A l\u2019estudi hi han participat 140 centres de 16 pa\u00efsos amb 8.144 fumadors categoritzats en dues cohorts: 4.116 pacients psiqui\u00e0trics i 4028 no psiqui\u00e0trics. <b>Conclou que tant la vareniclina<\/b> (agonista nicot\u00ednic)<b> com el bupropi\u00f3 <\/b>(antidepressiu, deshabituador del tabac)<b> no tenen efectes adversos neuropsiqui\u00e0trics significatius respecte al placebo<\/b>. Tots els tractaments analitzats (vareniclina, bupropi\u00f3 i TSN) s\u00f3n m\u00e9s efectius que el placebo.<\/p>\n<p>La prestigiosa revista <i>The Lancet<\/i> va publicar al mes d\u2019abril les dades de l&#8217;estudi EAGLES. Aquest assaig \u00e9s, fins avui, l&#8217;estudi cl\u00ednic m\u00e9s destacat que ha avaluat les opcions farmacol\u00f2giques disponibles per deixar de fumar.<\/p>\n<p><a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(16)30272-0\/abstract\" target=\"_blank\" rel=\"noopener\">Veure publicaci\u00f3 a The Lancet<\/a><\/div>\n<p><b>Les conclusions m\u00e9s rellevants s\u00f3n: <\/b><\/p>\n<ul>\n<li>La seguretat mostrada de tots els tractaments.<\/li>\n<li>La seguretat demostrada tamb\u00e9 en pacients amb problemes psiqui\u00e0trics controlats.<\/li>\n<li>El pacient psiqui\u00e0tric pot ser tractat amb qualsevol dels tres f\u00e0rmacs estudiats.<\/li>\n<li>Demostrada l\u2019efic\u00e0cia de tots els tractaments farmacol\u00f2gics enfront de placebo i per tant la seva evid\u00e8ncia cient\u00edfica.<\/li>\n<li>Que a les dosis estudiades i en monoter\u00e0pia, el tractament amb la vareniclina \u00e9s el que proporciona un m\u00e9s alt percentatge de cessaci\u00f3, comparada amb els altres.<\/li>\n<\/ul>\n<p>\u201cA partir d&#8217;aquest estudi <b>s&#8217;elimina l&#8217;advert\u00e8ncia de risc associat de la vareniclina i del bupropi\u00f3 dels seus prospectes<\/b>. Una altra conseq\u00fc\u00e8ncia destacable \u00e9s que <b>els pacients fumadors amb antecedents psiqui\u00e0trics estables podran utilitzar qualsevol dels tres tractaments per deixar de fumar sense por que la seva patologia de base sigui agreujada<\/b>. \u00c9s conegut que l&#8217;abandonament del tabac en malalt mental afavoreix la seva situaci\u00f3 personal i millora el seu estat en general. Per tant, s\u00f3n els m\u00e9s beneficiats del resultat d&#8217;aquest estudi\u201d explica <b>Montserrat Moral<\/b>, vicepresidenta de l\u2019SCATT.<\/p>\n<p>\u201cEn acabar l\u2019exposici\u00f3 hi va haver un interessant i espontani debat sobre les possibilitats que obre aquest estudi en l\u2019\u00fas de les eines farmacol\u00f2giques i la col\u00b7laboraci\u00f3 entre els diferents professionals sanitaris que aborden la cessaci\u00f3 tab\u00e0quica i en el que el col\u00b7lectiu farmac\u00e8utic t\u00e9 un important paper a aportar\u201d conclou <strong>Guillermo Bagaria<\/strong>, vocal del COFB.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-4.jpg\"><img decoding=\"async\" class=\" wp-image-23126 aligncenter\" alt=\"presentacio-estudi-EAGLES-tabaquisme-COFB (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/presentacio-estudi-EAGLES-tabaquisme-COFB-4.jpg\" width=\"594\" height=\"343\" \/><\/a><\/p>\n<p><b>Potser tamb\u00e9 t\u2019interessa:<\/b><\/p>\n<ul>\n<li><a href=\"http:\/\/blog.cofb.cat\/setmana-sense-fum-decideix-te-a-deixar-de-fumar-el-farmaceutic-et-pot-ajudar\/\">Setmana sense fum: decideix-te a deixar de fumar, el farmac\u00e8utic et pot ajudar<\/a> (Blog)<\/li>\n<li><a href=\"http:\/\/blog.cofb.cat\/la-farmacia-present-en-la-vi-jornada-de-la-societat-catalana-datencio-i-tractament-del-consum-de-tabac\/\">La farm\u00e0cia, present en la VI Jornada de la Societat Catalana d\u2019Atenci\u00f3 i Tractament del Consum de Tabac<\/a> (Blog)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23120,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,2441,2358,137,138],"class_list":["post-23116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-estudi-eagles","tag-scatt","tag-tabac","tag-tabaquisme"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-13T07:42:29+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES\",\"datePublished\":\"2016-07-13T07:42:29+00:00\",\"dateModified\":\"2016-07-13T07:42:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\"},\"wordCount\":632,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"estudi EAGLES\",\"SCATT\",\"tabac\",\"tabaquisme\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\",\"name\":\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-07-13T07:42:29+00:00\",\"dateModified\":\"2016-07-13T07:42:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","og_locale":"ca_ES","og_type":"article","og_title":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-07-13T07:42:29+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES","datePublished":"2016-07-13T07:42:29+00:00","dateModified":"2016-07-13T07:42:29+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/"},"wordCount":632,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","estudi EAGLES","SCATT","tabac","tabaquisme"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","url":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/","name":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-07-13T07:42:29+00:00","dateModified":"2016-07-13T07:42:29+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/07\/13\/tractaments-de-tabaquisme-presentacio-de-lestudi-eagles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Tractaments de tabaquisme: presentaci\u00f3 de l\u2019estudi EAGLES"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"L&#8217;estudi EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) \u00e9s un treball sobre la seguretat i efic\u00e0cia dels tractaments farmacol\u00f2gics de la cessaci\u00f3 tab\u00e0quica en pacients neuropsiqui\u00e0trics. El 6 de juliol es va presentar, per primer cop a l\u2019Estat, a la seu del COFB, en un acte organitzat [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/23116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=23116"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/23116\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=23116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=23116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=23116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}